Tracheostomy Products Market Size, Share & Trends Analysis Report By Demographics (Adults, Pediatrics/Neonatal), By Type (Tracheostomy Tubes, Ventilation Accessories), By Technique, By End Use, And Segment Forecasts, 2022 - 2030

Report Overview

The global tracheostomy products market size was valued at USD 193.8 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% over the forecast period from 2022 to 2030 owing to the growth in the incidence rate of chronic respiratory disorders like Cardiovascular Diseases (CVDs), diabetes, respiratory diseases, cancer, and other respiratory injuries. In addition, the increasing demand for tracheostomy accessories to support the growing number of surgeries performed worldwide keeps rising. COPD is one of the world’s major causes of mortality. As per the WHO, COPD affected over 251 million people globally in 2016.

The rising frequency of tobacco smoking and poor air quality, particularly in middle-income nations, are key factors contributing to a rise in COPD prevalence, resulting in an increased demand for tracheostomy care. The COVID-19 pandemic has dramatically increased the number of patients requiring respiratory assistance, including mechanical ventilation. These patients require mechanical ventilation for a long time; however, some of them require tracheostomy to allow for weaning and better utilization of hospital resources. The tracheostomy technique, however, is difficult to perform due to the production of aerosols and the significant risk of nosocomial transmission to healthcare staff. Although percutaneous tracheostomy (PCT) is the standard of therapy in many ICUs, it has a higher risk of producing aerosols than surgical tracheostomy.

However, the function of tracheostomy is assisting with weaning in COVID-19 patients. The growing healthcare expenditure and the economies of nations, such as the U.S., China, and India, among others are expected to provide profitable prospects for market players. Moreover, tracheostomy products are used in tracheostomy treatments including obstructive sleep apnea, chronic lung illness, anaphylaxis, throat cancer, coma, diaphragm malfunction, laryngectomy, and vocal cord paralysis, among others. The market is anticipated to grow due to favorable reimbursement policies, expanding healthcare infrastructure, and a high prevalence of respiratory diseases.

Type Insights

Based on type, the market is segmented into tracheostomy tubes, ventilation accessories, clean & care kits, and other accessories. In 2021, the tracheostomy tubes segment dominated the market with a share of more than 45% as these tubes are extensively used in tracheostomy procedures for anaphylactic, chronic respiratory illness, coma, esophageal cancer, laryngectomy, sleep apnea, vocal cord paralysis, and diaphragm malfunction, among others. Tracheostomy tubes provide substantial advantages, such as accurate precision, reduced threat of emissions and aspiration, elimination of intubations and laryngoscopies, and improved ventilation.

These tubes also offer end-tidal carbon dioxide monitoring as well as accurate tidal volume. The tracheostomy ventilation accessories segment is likely to grow at the fastest CAGR over the forecast period. Tracheostomy ventilation accessories include a respiratory mask, breathing circuit, filter and connector, expiratory valve, ECH and sensor, and test lung, among others. The rising demand for ventilation accessories is driven by the increased sales of portable mechanical ventilators. In addition, the increasing number of hospitals and academic medical institutes is contributing to the demand for ventilation systems, propelling the segment growth.

Technique Insights

Based on techniques, the global market has been further bifurcated into percutaneous dilatational tracheostomy and surgical tracheostomy. In 2021, the percutaneous dilatational tracheostomy segment dominated the market, in terms of revenue share, and is likely to expand further at the fastest growth rate of 4.6% over the forecast period. The percutaneous dilatational tracheostomy technique is considered more effective and safer than surgical procedures. It is less prone to developing any complications and can be performed in lesser time.

In addition, in severely ill patients, percutaneous dilatational tracheostomy is performed more frequently. The most common reason for percutaneous tracheostomy in critically ill patients is a prolonged ventilator-dependent hospital stay. The percutaneous dilatational tracheostomy technique has almost completely replaced surgical tracheostomy in the ICU in recent years on account of cost-effectiveness. In addition, it can be performed with ease at the patient’s bedside, eliminating the needless, and often risky, patient transfers to the Operating Rooms (ORs).

Demographics Insights

Based on demographics, the global market has been further segmented into adult patients and pediatric/neonatal patients. In 2021, the adult patients segment dominated the global market and accounted for the largest share of more than 83.00% of the overall revenue. The growth was attributed to the rapid population growth and increased incidence of various chronic diseases among the adult population that require prolonged hospital stays. One of the most prevalent ailments in adults admitted to the ICUs is respiratory failure with Invasive Mechanical Ventilation (IMV), with over 90% of adult patients requiring ICU treatment.

Patients with respiratory failure who need prolonged invasive mechanical ventilation with an endotracheal tube are offered a tracheostomy to relieve some of the uneasiness and risks associated with endotracheal tube usage. The pediatric/neonatal patients segment is also estimated to grow at a considerable CAGR from 2022 to 2030. However, a tracheotomy is less common in children than in adults. Among pediatric/neonatal patients, anatomical upper airway blockage is the most common reason for tracheostomy procedures in newborns.

End-use Insights

Based on end-use, the market is segmented into hospitals & surgery centers, ambulatory care centers, home care settings, and others. In 2021, the hospitals & surgery centers segment dominated the global market and accounted for the largest revenue share of more than 70%. This growth was attributed to hospitals’ financial capacity to acquire expensive products and equipment. Furthermore, tracheostomy products are widely employed in operating theatres, emergency care, and critical care settings. On the other hand, the home care settings segment is anticipated to register the fastest growth rate over the forecast period.

Home care is an important aspect of geriatric care. The underlying medical issues that are leading to the rising number of long-term tracheostomy patients requiring care in home settings are several. Patients having upper airway deformity or blockage requiring enhanced airway management, patients undergoing prolonged invasive ventilator support, and patients suffering from various disorders compromising the integrity of the upper airway management are responsible for the increasing demand for tracheostomy products and accessories in homecare settings.

Regional Insights

In 2021, North America dominated the market in terms of revenue share owing to the rapid development of innovative technologies and therapies for throat cancer, the growing presence of prominent players in the region, and developed healthcare infrastructure. Key factors, such as higher per capita healthcare spending and a significant number of people suffering from respiratory illnesses, also support the market growth. In addition, favorable government initiatives and an increase in the number of research collaborations are likely to boost the North America regional market growth. According to the CDC, over 9 million people in the U.S. were diagnosed with severe bronchitis in 2017.

Asia Pacific is projected to be the fastest-growing regional market registering a CAGR of 5.2% during the forecast period. The high growth can be attributed to the presence of countries in Asia Pacific that are densely populated and have high levels of pollution, which lead to the rising incidences of respiratory diseases. The rapid expansion of in-home care and treatment services is also estimated to augment the product demand in Asia Pacific, thereby supporting the regional market growth over the forecast period.

Key Companies & Market Share Insights

Technological advancements are boosting the demand for at-home services for critically ill patients. Key market players are focusing on enhancing their distribution capacities, particularly in emerging economies. For instance, Smiths Medical added a (PVC) tracheostomy tube portfolio to its tracheostomy tube lineup in January 2020. in addition, Cook Medical launched the blue rhino g2-multi percutaneous tracheostomy introducer kits with trays in January 2021 in the U.S. and Canada.

In November 2021, ConvaTec renewed its Advanced Wound Care Products partnership with Vizient, Inc. This new partnership includes wound formulary standardization and savings initiatives, which are projected to benefit Vizient members both clinically and financially, as well as increase ConvaTec’s market potential development. Some of the key market players operating in the global tracheostomy products market include:

• Pulmodyne, Inc.

• Smiths Group plc

• Medtronic

• TRACOE Medical GmbH

• Teleflex, Inc.

• Cook Group

• ConvaTec Group

• Boston Medical

• Fisher & Paykel Healthcare Ltd.

• Angiplast

Tracheostomy Products Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global tracheostomy products market report based on type, technique, demographics, end-use, and region:

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Tracheostomy Tubes

  • Ventilation Accessories

  • Clean & Care Kits

  • Others

• Technique Outlook (Revenue, USD Million, 2017 - 2030)

  • Percutaneous Dilatational Tracheostomy

  • Surgical Tracheostomy

• Demographics Outlook (Revenue, USD Million, 2017 - 2030)

  • Adult Patients

  • Pediatric/Neonatal Patients

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals & Surgery Centers

  • Ambulatory Care Centers

  • Home Care Settings

  • Others

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa